Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Recent Posts
Reversing the Reversal?: Government Puts Privacy Invasive Lawful Access Back on the Agenda 
Canadian Government Introduces New Stablecoin Act as Part of Budget Implementation Legislation 
The Law Bytes Podcast, Episode 250: Wikimedia’s Jan Gerlach on the Risks and Challenges with Digital Policy Reform 
The Law Bytes Podcast, Episode 249: The Debate Over Canada’s AI Strategy – My Consultation Submission and Appearance at the Canadian Heritage Committee 
How the Liberal and Conservative Parties Have Quietly Colluded to Undermine the Privacy Rights of Canadians
